Bausch Health Companies Inc. (NYSE: BHC) announced a definitive agreement to acquire DURECT Corporation (NASDAQ: DRRX) for $1.75 per share ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE